REVERSIBLE COVALENT PYRROLO- OR PYRAZOLOPYRIMIDINES USEFUL FOR THE TREATMENT CANCER AND AUTOIMMUNE DISEASES

Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production and use of these formulations for the treatment of diseases treatable by such compounds such as cancer and autoimmune diseases.

Saved in:
Bibliographic Details
Main Authors GOLDSTEIN DAVID MICHAEL, BERNER BRET
Format Patent
LanguageEnglish
Korean
Published 05.03.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production and use of these formulations for the treatment of diseases treatable by such compounds such as cancer and autoimmune diseases.
AbstractList Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production and use of these formulations for the treatment of diseases treatable by such compounds such as cancer and autoimmune diseases.
Author GOLDSTEIN DAVID MICHAEL
BERNER BRET
Author_xml – fullname: GOLDSTEIN DAVID MICHAEL
– fullname: BERNER BRET
BookMark eNqNi8sKwjAURLPQha9_uOC6UCvFdUxvaTAPuUkKuilF4kZpC_X_sQU_wNWZ4cys2aLru7hiL8IaycmzQhC25gqNh-uNyCqbgKU58_tUJkotC2nQQXBYBgXlpH2F4Am51_NRcCOQgJsCePBWah0MQiEdcoduy5bP9j3G3Y8bti_RiyqJQ9_EcWgfsYuf5kJZesjTNDue8owf_1t9AW1kOac
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20150023752A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20150023752A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:09:45 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20150023752A3
Notes Application Number: KR20157000923
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150305&DB=EPODOC&CC=KR&NR=20150023752A
ParticipantIDs epo_espacenet_KR20150023752A
PublicationCentury 2000
PublicationDate 20150305
PublicationDateYYYYMMDD 2015-03-05
PublicationDate_xml – month: 03
  year: 2015
  text: 20150305
  day: 05
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies PRINCIPIA BIOPHARMA, INC
RelatedCompanies_xml – name: PRINCIPIA BIOPHARMA, INC
Score 2.9356668
Snippet Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production and use of these...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title REVERSIBLE COVALENT PYRROLO- OR PYRAZOLOPYRIMIDINES USEFUL FOR THE TREATMENT CANCER AND AUTOIMMUNE DISEASES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150305&DB=EPODOC&locale=&CC=KR&NR=20150023752A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8Iw8IJo1DdFjR9ommj2tjj3weCBmNF1AdkHKRtBX8g-SmIwQGTGv-9tgvLEU6-9pGmb-2x7dwAPSSttKUqayHEzy2RdFbrcTM1YRtWk6llsqKIMj_b8RjfSX8bGuAIfm1iYMk_od5kcETkqRX7PS3m9_L_Essu_lavH5B2HFs9O2LaltXeM1g3Sr2R32mwQ2AGVKG33ueTzXxzqJ9NQrT3YR0PaLPiBjTpFXMpyW6k4J3AwwPnm-SlUZosaHNFN7bUaHHrrJ28E19y3OoMZZyPGh72OywgNRpbL_JAMXjkP3EAmAS9g6w072KJMsouCGiQaMidyCTp7JOwyEnJmhUUCf0KLsjScWL5NkEiDnudFPiN2b8gslLHncO-wkHZlXPXk75Amfb69Re0CqvPFXFwCaRoZmkCapsRapk8boqWIbIp-RGZqT-lUPF1BfddM17vRN3BcdMtfWUYdqvnnl7hFNZ0nd-Xp_gB-4I23
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3bTsIw9ATRiG-KGi-oTTR7Wxy7MHggZmxdNtmFlI0gL2Q3EoMBIjP-vmcTlCeeetqTNG3Tc2vPBeAp7iQdQUhiPmqnKS-Lmcy3EzXiUTSJchopYlaGR7teywrl17EyrsDHNhamzBP6XSZHRIpKkN7zkl-v_h-xjNK3cv0cv-PQ8sUMuga3sY5Ru8H7yxm9Lh34hq9zut7tM85jvziUT6oiagdwiEq2WtADHfWKuJTVrlAxT-FogPMt8jOozJd1qOnb2mt1OHY3X94IbqhvfQ5zRkeUDe2eQ4nujzSHegEZvDHmOz5PfFbA2gQ72CJPMoqCGiQcUjN0CBp7JLAoCRjVgiKBP9GLsjSMaJ5B8JL6tuuGHiWGPaQa8tgLeDRpoFs8rnr6d0jTPtvdonQJ1cVykV0BaSspqkCSJERSKs9aWUfI0hnaEakqNZNZ1ryGxr6ZbvajH6BmBa4zdWyvfwsnBar00FIaUM0_v7I7FNl5fF-e9A9RuZCq
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=REVERSIBLE+COVALENT+PYRROLO-+OR+PYRAZOLOPYRIMIDINES+USEFUL+FOR+THE+TREATMENT+CANCER+AND+AUTOIMMUNE+DISEASES&rft.inventor=GOLDSTEIN+DAVID+MICHAEL&rft.inventor=BERNER+BRET&rft.date=2015-03-05&rft.externalDBID=A&rft.externalDocID=KR20150023752A